Cytek Biosciences Inc. Gains 36.03%

Wed, Nov 06, 2024 at 07:29 PM

Cytek Biosciences Inc. (CTKB:NASDAQ) soared at $7.4, representing a gain of 36%. On Wed, Nov 06, 2024, CTKB:NASDAQ touched a New 2-Week High of $7.4. The stock got featured on our News Catalysts scanner on Wed, Nov 06, 2024 at 04:36 AM in the 'MISCELLANEOUS' category. From Wed, Oct 23, 2024, the stock recorded 70.00% Up Days and 63.64% Green Days

About Cytek Biosciences Inc. (CTKB:NASDAQ)

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.

Top 10 Gainers:

SRAX, Inc. (SRAX:NASDAQ), 2841.18%
FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 475.02%
Trilogy Metals Inc. (TMQ:NYSEMKT), 79.26%
FREYR Battery (FREY:NYSE), 66.67%
ARB IOT Group Limited (ARBB:NASDAQ), 44.09%
Earlyworks Co. Ltd. (ELWS:NASDAQ), 43.29%
The GEO Group, Inc. (GEO:NYSE), 42.1%
Destiny Tech100 Inc. (DXYZ:NYSE), 37.1%
Cytek Biosciences Inc. (CTKB:NASDAQ), 36.03%
Treace Medical Concepts Inc. (TMCI:NASDAQ), 35.07%